| INVITED DRUG REVIEW |
|
| Year : 2022 | Volume
: 24
| Issue : 1 | Page : 1-7 |
|
|
Isavuconazole - The new triazole
Jayanthi Savio
Department of Microbiology, St. John's Medical College and Hospital, St. John's National Academy of Health Sciences, Bengaluru, Karnataka, India
Correspondence Address:
Dr. Jayanthi Savio
Department of Microbiology, St. John's Medical College and Hospital, St. John's National Academy of Health Sciences, Sarjapur Road, Bengaluru - 560 034, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jacm.jacm_11_22
|
|
|
The increase in susceptible population to invasive fungal infections, especially candidemia and aspergillosis has resulted in the introduction of newer antifungal agents, especially in the azole group. Isavuconazole is one such agent with an extended antifungal spectrum. It is found to be useful not only in the management of candidemia and aspergillosis but also mucormycosis.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
